Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Rekombinanter VWF Antikörper (AA 1815-1939)

Dieses Anti-VWF-Antikörper ist ein Kaninchen Monoklonal-Antikörper zur Detektion von VWF in WB und IHC (f). Geeignet für Human.
Produktnummer ABIN6938779

Kurzübersicht für Rekombinanter VWF Antikörper (AA 1815-1939) (ABIN6938779)

Target

Alle VWF Antikörper anzeigen
VWF (Von Willebrand Factor (VWF))

Antikörpertyp

Recombinant Antibody

Reaktivität

  • 225
  • 44
  • 32
  • 12
  • 7
  • 6
  • 2
  • 1
Human

Wirt

  • 133
  • 130
  • 13
  • 7
  • 1
  • 1
  • 1
Kaninchen

Klonalität

  • 158
  • 123
  • 2
Monoklonal

Konjugat

  • 133
  • 29
  • 18
  • 11
  • 9
  • 9
  • 9
  • 9
  • 9
  • 9
  • 7
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser VWF Antikörper ist unkonjugiert

Applikation

  • 188
  • 161
  • 80
  • 74
  • 63
  • 56
  • 49
  • 46
  • 25
  • 16
  • 16
  • 15
  • 9
  • 9
  • 8
  • 6
  • 5
  • 5
  • 5
  • 4
  • 4
  • 3
  • 3
  • 3
  • 1
  • 1
Western Blotting (WB), Immunohistochemistry (Formalin-fixed Sections) (IHC (f))

Klon

VWF-1859R
  • Bindungsspezifität

    • 54
    • 22
    • 16
    • 11
    • 9
    • 8
    • 6
    • 4
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 1815-1939

    Spezifität

    Von Willebrand Factor (vWF) is a multimeric glycoprotein that is found in endothelial cells, plasma and platelets. It acts as a carrier protein for Factor VIII and promotes platelet adhesion and aggregation. vWF undergoes a variety of posttranslational modifications that influence the affinity and availability for Factor VIII, including cleavage of the propeptide and formation of N-terminal disulfide bonds. This antibody helps to establish the endothelial nature of some lesions of disputed histogenesis, e.g. Kaposi's sarcoma and cardiac myxoma. It is widely used for differentiating vascular lesions from those of other tissue differentiation within a panel of other vascular markers although not all tumors of endothelial differentiation contain this antigen.

    Kreuzreaktivität (Details)

    Human.

    Aufreinigung

    1.0mg/ml of Ab purified from Bioreactor by Protein A/G.

    Immunogen

    Recombinant fragment of human vWF protein (aa1815-1939) (exact sequence is proprietary)

    Isotyp

    IgG
  • Applikationshinweise

    Known_Application: Western Blot (1-2 μg/mL), Immunohistochemistry (Formalin-fixed) (1-2 μg/mL for 30 minutes at RT) (Staining of formalin-fixed tissues requires heating tissue sections in 10 mM Tris with 1 mM EDTA, pH 9.0, for 45 min at 95°C followed by cooling at RT for 20 minutes), Optimal dilution for a specific application should be determined.

    Positive_Control: HUVEC cells. Tonsil.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Konzentration

    1.0 mg/mL

    Buffer

    Prepared in 10 mM PBS, WITHOUT BSA and Azide.

    Konservierungsmittel

    Azide free

    Lagerung

    -20 °C,-80 °C

    Informationen zur Lagerung

    Antibody without azide store at -20 to -80 °C. Antibody is stable for 24 months. Non-hazardous.

    Haltbarkeit

    24 months
  • Target

    VWF (Von Willebrand Factor (VWF))

    Andere Bezeichnung

    VWF

    Hintergrund

    Coagulation Factor VIII, Factor VIII Related Antigen, F8VWF, von Willebrand Antigen 2, von Willebrand Disease (vWD),von Willebrand Factor / Factor VIII Related-Ag (Endothelial Marker)
    Cellular localisation: Cytoplasmic

    Molekulargewicht

    250kDa

    Gen-ID

    7450, 440848

    UniProt

    P04275
Sie sind hier:
Chat with us!